Zen-Bio

Durham, United States Founded: 1995 • Age: 31 yrs Acquired By BioIVT
Cell-based solutions are provided to accelerate therapy discovery and development.
Annual revenue - Latest available
Total funding - 11 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 6 Services tracked
Competitors 10 Brand Intelligence

About Zen-Bio

Zen-Bio is a company based in Durham (United States) founded in 1995 was acquired by BioIVT in August 2024. Zen-Bio offers products and services including Blood/Serum Products, Cell Extracts, Human Exosomes, Labware, and Media. Zen-Bio operates in a competitive market with competitors including Anabios, Clyde Biosciences, Metrion Biosciences, Quiver Bioscience and Rules-Based Medicine, among others.

  • Headquarter Durham, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Zenbio, Inc.
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $251.14 K (USD), Grant

    Aug 29, 2011

  • Investors
    HHS

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    BioIVT

    (Aug 21, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Zen-Bio

Zen-Bio offers a comprehensive portfolio of products and services, including Blood/Serum Products, Cell Extracts, Human Exosomes, Labware, and Media.

Primary

Provides human and animal blood components for research use.

Offers extracts from human tissues for scientific studies.

Delivers exosomes from stem cells for regenerative research.

Supplies ECM coated plastics for cell culture applications.

Formulates media for optimal cell growth in experiments.

Provides kits for testing compounds in metabolic diseases.

Funding Insights of Zen-Bio

  • Total Funding
  • Total Rounds 11
  • Last Round Grant — $251,144
  • First Round

    (19 May 2008)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2011 Amount Grant - Zen-Bio Valuation

investors

HHS
Oct, 2010 Amount Grant - Zen-Bio Valuation

investors

HHS
Sep, 2010 Amount Grant - Zen-Bio Valuation

investors

HHS

Investors in Zen-Bio

Zen-Bio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and BioIVT.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Provider of in vitro diagnostic products and assay services
Founded Year Domain Location

Investments & Acquisitions by Zen-Bio

Investments

Financial Statements - Zen-Bio

Zen-Bio Comparisons

+
Add Comparison
Available on Premium

Competitors of Zen-Bio

Zen-Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Anabios, Clyde Biosciences, Metrion Biosciences, Quiver Bioscience and Rules-Based Medicine, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Ex-vivo human tissue studies are performed for preclinical drug discovery.
domain founded_year HQ Location
Cardiac safety testing is conducted using iPS-derived heart cells.
domain founded_year HQ Location
Ion channel screening and cardiac safety profiling services are provided.
domain founded_year HQ Location
Developer of transformational medicines for neurological disorders
domain founded_year HQ Location
Multiplexed immunoassays for protein biomarkers are developed via proprietary platform.

Latest news on Zen-Bio

Frequently Asked Questions about Zen-Bio

Zen-Bio was founded in 1995 and raised its 1st funding round 13 years after it was founded.

Zen-Bio is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.

Founded in 1995 and based in Durham, United States, Zen-Bio operates in the biotechnology sector, focusing on metabolic diseases and cosmeceuticals. Human cell-based products, including cells, tissues, and serum from diverse donor populations and disease states such as type II diabetes and hypertension, are supplied. Contract research services, cell-based assay development, custom consultations, cell characterization, and molecular biology services are offered to support therapy development.

Zen-Bio's top competitors include Metrion Biosciences, Quiver Bioscience and Anabios.

Zen-Bio offers Blood/Serum Products, Cell Extracts, Human Exosomes, Labware, and 2 more products and services.

Zen-Bio has 2 investors. Key investors include HHS, and BioIVT.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available